Abstract
Introduction and hypothesis
At our institution, every patient seen by the gynecologic oncology service is screened for pelvic floor dysfunction. This study was aimed at determining if a combined surgical approach by gynecologic oncology and urogynecology services at our institution was feasible and safe for this patient population.
Methods
We performed a retrospective review of patients undergoing combined surgery by gynecologic oncology and urogynecology services at our institution from 2013 to 2021. Perioperative variables, postoperative adverse events, and long-term outcomes were assessed, and descriptive statistics were performed.
Results
From 20 December 2013 to 29 January 2021, a total of 102 patients underwent concurrent surgical repair of pelvic organ prolapse and/or stress urinary incontinence. Seventy-three patients (71.6%) had normal/benign pathologic conditions, and 29 (28.4%) had premalignant/malignant pathologic conditions. Ten patients (9.8%) had a postoperative complication, including reoperation for exposed midurethral sling (4.9%), urinary retention requiring midurethral sling release (2.9%), reoperation for hemoperitoneum (1.0%), and anemia requiring blood transfusion (1.0%). Nine complications occurred in patients with benign/normal pathologic conditions (12.3%), and one complication occurred in patients with pre-malignant/malignant pathologic conditions (3.4%).
Conclusions
In our single-institution experience, concurrent gynecologic oncology and pelvic floor reconstructive surgery were safe and feasible in combination with no reported major morbidity events.
Similar content being viewed by others
Abbreviations
- PFD:
-
Pelvic floor dysfunction
- POP:
-
Pelvic organ prolapse
- QoL:
-
Quality of life
- SUI:
-
Stress urinary incontinence
- UI:
-
Urinary incontinence
References
Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6. https://doi.org/10.1001/jama.300.11.1311.
Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141–8. https://doi.org/10.1097/AOG.0000000000000057.
Thomas SG, Sato HRN, Glantz JC, Doyle PJ, Buchsbaum GM. Prevalence of symptomatic pelvic floor disorders among gynecologic oncology patients. Obstet Gynecol. 2013;122(5):976–80. https://doi.org/10.1097/AOG.0b013e3182a7ef3c.
Rutledge TL, Heckman SR, Qualls C, Muller CY, Rogers RG. Pelvic floor disorders and sexual function in gynecologic cancer survivors: a cohort study. Am J Obstet Gynecol. 2010;203(5):514.e1–7. https://doi.org/10.1016/j.ajog.2010.08.004.
Ramaseshan AS, Felton J, Roque D, Rao G, Shipper AG, Sanses TVD. Pelvic floor disorders in women with gynecologic malignancies: a systematic review. Int Urogynecol J. 2018;29(4):459–76. https://doi.org/10.1007/s00192-017-3467-4.
Nygaard I, Turvey C, Burns TL, Crischilles E, Wallace R. Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol. 2003;101(1):149–56. https://doi.org/10.1016/s0029-7844(02)02519-x.
Iavazzo C, Vorgias G, Vecchini G, Katsoulis M, Akrivos T. Vaginal carcinoma in a completely prolapsed uterus. A case report. Arch Gynecol Obstet. 2007;275(6):503–5. https://doi.org/10.1007/s00404-006-0284-2.
Cabrera S, Franco-Camps S, Garcia A, et al. Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus. Arch Gynecol Obstet. 2010;282(1):63–7. https://doi.org/10.1007/s00404-010-1472-7.
da Silva BB, da Costa AR, Filho CP, Melo JA. Carcinoma of the cervix in association with uterine prolapse. Gynecol Oncol. 2002;84(2):349–50. https://doi.org/10.1006/gyno.2001.6503.
Bretschneider CE, Sheyn D, Mahajan ST, Ferrando CA. Adverse events after concurrent procedures for gynecologic malignancies and pelvic floor disorders. Obstet Gynecol. 2018;132(2):274–80. https://doi.org/10.1097/AOG.0000000000002731.
Panchal H, Matros E. Current trends in postmastectomy breast reconstruction. Plast Reconstr Surg. 2017. 140(5S):7S–13S. doi:https://doi.org/10.1097/PRS.0000000000003941.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.
Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009;27(32):5331–6. https://doi.org/10.1200/JCO.2009.22.3248.
Manodoro S, Frigerio M, Milani R, Spelzini F. Tips and tricks for uterosacral ligament suspension: how to avoid ureteric injury. Int Urogynecol J. 2018;29(1):161–3. https://doi.org/10.1007/s00192-017-3497-y.
Clancy AA, Mallick R, Breau RH, Khalil H, Hickling DR. Complications after minimally invasive sacrocolpopexy with and without concomitant incontinence surgery: a National Surgical Quality Improvement Program (NSQIP) database study. Neurourol Urodyn. 2018;37(7):2234–41. https://doi.org/10.1002/nau.23574.
Kohut A, Earnhardt MC, Cuccolo NG, et al. Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer. Gynecol Oncol. 2020;156(1):162–8. https://doi.org/10.1016/j.ygyno.2019.08.023.
Uppal S, Al-Niaimi A, Rice LW, et al. Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecol Oncol. 2013;131(2):416–22. https://doi.org/10.1016/j.ygyno.2013.08.011.
Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99(1):153–9. https://doi.org/10.1016/j.ygyno.2005.05.034.
Mahdi H, Jernigan AM, Aljebori Q, Lockhart D, Moslemi-Kebria M. The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer. J Minim Invasive Gynecol. 2015;22(1):94–102. https://doi.org/10.1016/j.jmig.2014.07.014.
Kohut A, Orfanelli T, Poggio JL, Gibbon D, Buckley De Meritens A, Richard S. Morbidity and mortality risk assessment in gynecologic oncology surgery using the American College of Surgeons National Surgical Quality Improvement Program Database. Int J Gynecol Cancer. 2018;28(4):840–7. https://doi.org/10.1097/IGC.0000000000001234.
Abed H, Rahn DD, Lowenstein L, et al. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. 2011;22(7):789–98. https://doi.org/10.1007/s00192-011-1384-5.
Moore RD, Lukban JC. Comparison of vaginal mesh extrusion rates between a lightweight type I polypropylene mesh versus heavier mesh in the treatment of pelvic organ prolapse. Int Urogynecol J. 2012;23(10):1379–86. https://doi.org/10.1007/s00192-012-1744-9.
Klopp A, Smith BD, Alektiar K, et al. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014;4(3):137–44. https://doi.org/10.1016/j.prro.2014.01.003.
Chino J, Annunziata CM, Beriwal S, et al. The ASTRO clinical practice guidelines in cervical cancer: optimizing radiation therapy for improved outcomes. Gynecol Oncol. 2020;159(3):607–10. https://doi.org/10.1016/j.ygyno.2020.09.015.
Acknowledgements
We would like to thank student, Chikezie Okeiyi, for assisting in data collection for this project.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
A. Kohut: protocol and project development, data collection and management, data analysis, manuscript writing, and editing; T. Whitaker: manuscript writing and editing; L. Walter: data collection and management; S.Y. Li: data collection and management; E. Han: data collection and management; S. Lee: protocol and project development, data analysis, manuscript writing, and editing; M.T. Wakabayashi: protocol and project development, data analysis, manuscript writing, and editing; T.H. Dellinger: protocol and project development, data analysis, manuscript writing, and editing; E.S. Han: protocol and project development, data analysis, manuscript writing, and editing; L. Rodriguez-Rodriguez: protocol and project development, data analysis, manuscript writing, and editing; C. Chung: protocol and project development, data collection and management, data analysis, manuscript writing, and editing.
Corresponding author
Ethics declarations
Disclaimer
The views expressed in this article are solely of the contributing authors and not an official position of City of Hope National Medical Center.
Conflicts of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Kohut, A., Whitaker, T., Walter, L. et al. Feasibility of combining pelvic reconstruction with gynecologic oncology-related surgery. Int Urogynecol J 34, 177–183 (2023). https://doi.org/10.1007/s00192-022-05212-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-022-05212-7